Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.

Rocío Muñoz-HernándezSheila GatoAntonio Gil-GómezRocío AllerAngela RojasLaura MoránJavier GallegoElena Blázquez-LópezRocío Gallego-DuránRocío Montero-VallejoVanessa García-FernándezDouglas Maya-MilesMaría Del C RicoFrancisco J Cubero Javier VaqueroJavier AmpueroRafael BañaresManuel Romero

Published in: Liver international : official journal of the International Association for the Study of the Liver (2023)

Circulating levels of EpCAM+ CD133+ MVs in clinical and experimental NAFLD were increased in the presence of steatohepatitis, showing high potential as a non-invasive biomarker for the evaluation and management of these patients.

Keyphrases

end stage renal disease
circulating tumor cells
ejection fraction
newly diagnosed
chronic kidney disease
cell adhesion
type diabetes
peritoneal dialysis
high fat diet
nk cells
risk assessment
metabolic syndrome
adipose tissue